CDNA
$64.00-4.01%
CDNA financial statements
The full income statement, balance sheet, and cash-flow statement for CareDx Inc. (CDNA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 52.7M2024-09 53.6M2024-12 55.4M2025-03 55.7M2025-06 53.2M2025-09 51.4M2025-12 51.2M2026-03 51.7M2026-06 51.7M-1.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 380M+13.8% | 334M+19.1% | 280M-12.9% | 322M+8.6% | 296M+54.2% | |
| 411M+40.1% | 293M-39.4% | 484M+21.2% | 399M+22.4% | 326M+51.9% | ||
| Research & development | 71.4M-1.5% | 72.5M-12.0% | 82.4M-8.8% | 90.4M+18.1% | 76.5M+56.4% | |
| Selling, general & administrative | 108M-14.0% | 125M+5.3% | 119M+18.4% | 100M+33.9% | 75.0M+53.6% | |
| General & administrative | 108M-14.0% | 125M+5.3% | 119M+18.4% | 100M+33.9% | 75.0M+53.6% | |
| Selling & marketing | 103M+25.2% | 82.0M-2.5% | 84.1M-12.5% | 96.0M+24.3% | 77.2M+43.4% | |
| Restructuring | — | 1.78M-23.1% | 2.32M | 0.00 | 0.00 | |
| Amortization of intangibles | 6.35M+0.1% | 6.35M-1.9% | 6.47M+3.8% | 6.23M+7.5% | 5.80M+20.8% | |
| Operating income | -30.8M-175.5% | 40.8M+120.0% | -203M-163.3% | -77.2M-159.8% | -29.7M-32.0% | |
| Other non-operating income | 524K+59.3% | 329K-75.7% | 1.35M+147.1% | -2.87M-9.3% | -2.63M-224.0% | |
| Gain (loss) on equity securities | 0.00 | 0.00-100.0% | 1.50M+227.0% | -1.18M+32.2% | -1.74M | |
| Pre-tax income | -21.1M-139.9% | 52.9M+127.8% | -190M-149.4% | -76.2M-137.6% | -32.1M-62.5% | |
| Income tax | 271K-12.6% | 310K+119.9% | 141K-62.8% | 379K+126.6% | -1.43M-37.6% | |
| -21.4M-140.6% | 52.5M+127.6% | -190M-148.4% | -76.6M-149.9% | -30.7M-63.8% | ||
| Net income to common | -21.4M-140.6% | 52.5M+127.6% | -190M-148.4% | -76.6M-149.9% | -30.7M | |
| -$0.40-143.0% | $0.93+126.3% | -$3.54-145.8% | -$1.44-144.1% | -$0.59-47.5% | ||
| EPS (basic) | -$0.40-140.0% | $1.00+128.2% | -$3.54-145.8% | -$1.44-144.1% | -$0.59-47.5% | |
| Weighted-avg shares (basic) | 53.3M+1.0% | 52.8M-1.8% | 53.8M+0.8% | 53.3M+2.1% | 52.2M+12.4% | |
| Weighted-avg shares (diluted) | 53.3M-5.9% | 56.6M+5.3% | 53.8M+0.8% | 53.3M+2.1% | 52.2M+12.4% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 257M-26.9% | 352M+12.2% | 314M-19.1% | 388M-10.5% | 433M+58.7% | ||
| Cash & equivalents | 65.4M-43.0% | 115M+39.5% | 82.2M-8.6% | 89.9M-74.2% | 348M+158.8% | |
| Short-term investments | 112M-23.4% | 146M-4.7% | 153M-24.6% | 203M | 0.00-100.0% | |
| Cash & short-term investments | — | — | 235M-19.7% | 293M | — | |
| Accounts receivable | 42.6M-34.0% | 64.6M+26.5% | 51.1M-23.0% | 66.3M+11.0% | 59.8M+72.6% | |
| Inventory | 26.7M+36.9% | 19.5M+0.2% | 19.5M+1.2% | 19.2M+11.9% | 17.2M+71.7% | |
| Prepaid expenses | 10.6M+49.8% | 7.07M-8.9% | 7.76M-15.8% | 9.22M+16.2% | 7.93M+111.0% | |
| 413M-15.8% | 491M+5.2% | 467M-14.0% | 543M-4.2% | 567M+53.8% | ||
| Property, plant & equipment | 33.0M-1.7% | 33.6M-4.8% | 35.2M-0.8% | 35.5M+61.2% | 22.0M+105.9% | |
| Operating lease right-of-use | 22.8M-6.5% | 24.3M-18.6% | 29.9M-13.8% | 34.7M+92.8% | 18.0M+18.2% | |
| Goodwill | 40.3M+0.0% | 40.3M+0.0% | 40.3M+7.5% | 37.5M+1.5% | 37.0M+55.0% | |
| Intangible assets | 32.0M-16.3% | 38.2M-16.4% | 45.7M+6.2% | 43.1M-14.2% | 50.2M+13.2% | |
| Long-term investments | 24.2M | 0.00 | — | — | — | |
| Other non-current assets | 3.35M+51.0% | 2.22M+64.2% | 1.35M-64.7% | 3.83M-34.4% | 5.83M+483.5% | |
| 89.8M+0.5% | 89.4M+14.5% | 78.1M+2.8% | 76.0M-1.7% | 77.3M+11.7% | ||
| Accounts payable | 9.99M+30.0% | 7.69M-40.3% | 12.9M+29.5% | 9.94M-25.5% | 13.3M+38.2% | |
| Deferred revenue | 4.65M-4.0% | 4.85M+2.1% | 4.75M-11.1% | 5.34M+26.9% | 4.21M+19.2% | |
| Current lease liability | 6.51M+6.8% | 6.10M+2.7% | 5.94M+6.3% | 5.59M+41.3% | 3.96M+94.7% | |
| 110M-2.2% | 113M-45.2% | 205M+83.3% | 112M+11.3% | 101M+10.9% | ||
| Non-current lease liability | 19.7M-11.6% | 22.3M-21.3% | 28.3M-15.4% | 33.4M+92.1% | 17.4M+8.2% | |
| Operating lease liability (total) | 26.2M-7.7% | 28.4M-17.1% | 34.2M-12.2% | 39.0M+82.6% | 21.4M | |
| Deferred tax liabilities | 181K+10.4% | 164K+20.6% | 136K | 0.00-100.0% | 415K-68.1% | |
| Other non-current liabilities | 418K-35.2% | 645K-99.3% | 96.6M+38675.5% | 249K-45.3% | 455K+89.6% | |
| 303M-19.9% | 378M+44.8% | 261M-39.4% | 431M-7.5% | 466M+67.8% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 50.0K-2.0% | 51.0K+4.1% | 49.0K-5.8% | 52.0K+0.0% | 52.0K+6.1% | |
| Additional paid-in capital | 927M-8.5% | 1.01B+7.0% | 947M+5.3% | 899M+5.3% | 854M+35.0% | |
| Retained earnings | -619M+1.2% | -626M+7.7% | -678M-47.3% | -460M-20.2% | -383M-8.7% | |
| Accumulated other comprehensive income | -5.51M+35.6% | -8.57M-23.1% | -6.96M+7.2% | -7.50M-60.7% | -4.67M-122.8% | |
| Total equity incl. non-controlling | — | — | — | 431M-7.5% | 466M+67.8% | |
| Total liabilities & equity | 413M-15.8% | 491M+5.2% | 467M-14.0% | 543M-4.2% | 567M+53.8% | |
| Common shares issued | 50.9M-7.0% | 54.8M+6.3% | 51.5M-3.9% | 53.6M+1.2% | 52.9M+7.0% | |
| Common shares outstanding | 50.9M-7.0% | 54.8M+6.3% | 51.5M-3.8% | 53.5M+1.2% | 52.9M+7.0% | |
| Shares outstanding (cover) | 51.2M-7.6% | 55.4M+7.0% | 51.8M-3.5% | 53.7M+1.2% | 53.0M+2.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 42.0M+10.5% | 38.0M+306.9% | -18.4M+27.1% | -25.2M-30.8% | -19.3M-157.7% | ||
| Depreciation & amortization | 15.0M+5.8% | 14.2M-1.3% | 14.4M+24.1% | 11.6M+31.8% | 8.80M+25.6% | |
| Intangible amortization | 6.35M+0.1% | 6.35M-1.9% | 6.47M+3.8% | 6.23M+7.5% | 5.80M+20.8% | |
| Share-based compensation | 34.9M-47.5% | 66.4M+35.3% | 49.1M+5.4% | 46.6M+29.0% | 36.1M+54.2% | |
| Deferred income taxes | -149K-247.5% | 101K+40.3% | 72.0K+125.9% | -278K+79.8% | -1.38M-21.0% | |
| Change in receivables | -22.5M-263.9% | 13.7M+185.8% | -16.0M-340.5% | 6.66M-72.7% | 24.4M+134.7% | |
| Change in inventory | 4.96M+387.1% | 1.02M+1985.2% | -54.0K-101.9% | 2.86M-58.7% | 6.93M+116.7% | |
| 2.16M+546.8% | -483K-101.2% | 40.4M+117.7% | -229M-578.9% | 47.7M+147.5% | ||
| Acquisitions | 0.00 | 0.00-100.0% | 6.68M+995.4% | 610K-96.0% | 15.4M | |
| -93.4M-1566.0% | -5.61M+81.1% | -29.6M-552.8% | -4.54M-102.4% | 186M+13.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 189M | |
| Common stock repurchased | 87.8M+16713.8% | 522K-98.1% | 27.5M+4189.9% | 642K | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -49.3M-251.7% | 32.5M+524.2% | -7.66M+97.0% | -258M-220.8% | 214M+121.6% | |
| Interest paid | — | 0.00 | 0.00-100.0% | 8.00K+700.0% | 1.00K-90.0% | |
| Income taxes paid | 284K-10.4% | 317K-57.0% | 738K+88.3% | 392K+2700.0% | 14.0K-82.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 965M-18.7% | 1.19B+82.8% | 649M+6.3% | 611M-74.7% | 2.41B-35.8% | |
| P/E | — | 22.6× | — | — | — | |
| P/S | 2.5×-28.5% | 3.6×+62.7% | 2.2×+14.0% | 1.9×-76.4% | 8.1×-58.4% | |
| P/B | 3.2×+1.5% | 3.1×+90.4% | 1.6×+17.7% | 1.4×-73.0% | 5.2×-61.7% | |
| Earnings yield | — | 4.4% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CDNA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CDNA filings on SEC EDGAR → Not investment advice.